Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armand Sprecher

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|July 20, 2023
Limited Benefit of Postexposure Prophylaxis With VSV-EBOV in Ebola Virus-Infected Rhesus MacaquesTrenton Bushmaker, Friederike Feldmann, Jamie Lovaglio, et al.
The Journal of Infectious Diseases|July 2, 2016
Environmental Contamination and Persistence of Ebola Virus RNA in an Ebola Treatment CenterPhilippe Guillaume Poliquin, Florian Vogt, Miriam Kasztura, et al.
The Lancet. Microbe|May 26, 2022
Evaluation of viral load in patients with Ebola virus disease in Liberia: a retrospective observational studyM Jeremiah Matson, Emily Ricotta, Friederike Feldmann, et al.
Plos Neglected Tropical Diseases|June 2, 2011
The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in AngolaAllen Grolla, Steven M Jones, Lisa Fernando, et al.
The New England Journal of Medicine|August 23, 2018
Outbreaks in a Rapidly Changing Central Africa - Lessons from EbolaVincent J Munster, Daniel G Bausch, Emmie de Wit, et al.
Emerging Infectious Diseases|January 27, 2016
Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, GuineaRafael Van den Bergh, Pascale Chaillet, Mamadou Saliou Sow, et al.
Global Health Action|April 26, 2024
Methodological issues of retrospective surveys for measuring mortality of highly clustered diseases: case study of the 2014-16 Ebola outbreak in Bo District, Sierra LeoneGrazia Caleo, Kamalini Lokuge, Katina Kardamanidis, et al.
Nature Communications|July 29, 2020
Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatmentRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
BMC Infectious Diseases|February 12, 2020
Prioritising pathogens for the management of severe febrile patients to improve clinical care in low- and middle-income countriesJennifer Osborn, Teri Roberts, Ethan Guillen, et al.
Emerging Infectious Diseases|February 21, 2025
Adaptive Design for Phase II/III Platform Trial of Lassa Fever TherapeuticsJosephine Bourner, Michel Vaillant, Alex Paddy Abdel Salam, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|July 20, 2023
Limited Benefit of Postexposure Prophylaxis With VSV-EBOV in Ebola Virus-Infected Rhesus MacaquesTrenton Bushmaker, Friederike Feldmann, Jamie Lovaglio, et al.
The Journal of Infectious Diseases|July 2, 2016
Environmental Contamination and Persistence of Ebola Virus RNA in an Ebola Treatment CenterPhilippe Guillaume Poliquin, Florian Vogt, Miriam Kasztura, et al.
The Lancet. Microbe|May 26, 2022
Evaluation of viral load in patients with Ebola virus disease in Liberia: a retrospective observational studyM Jeremiah Matson, Emily Ricotta, Friederike Feldmann, et al.
Plos Neglected Tropical Diseases|June 2, 2011
The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in AngolaAllen Grolla, Steven M Jones, Lisa Fernando, et al.
The New England Journal of Medicine|August 23, 2018
Outbreaks in a Rapidly Changing Central Africa - Lessons from EbolaVincent J Munster, Daniel G Bausch, Emmie de Wit, et al.
Emerging Infectious Diseases|January 27, 2016
Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, GuineaRafael Van den Bergh, Pascale Chaillet, Mamadou Saliou Sow, et al.
Global Health Action|April 26, 2024
Methodological issues of retrospective surveys for measuring mortality of highly clustered diseases: case study of the 2014-16 Ebola outbreak in Bo District, Sierra LeoneGrazia Caleo, Kamalini Lokuge, Katina Kardamanidis, et al.
Nature Communications|July 29, 2020
Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatmentRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
BMC Infectious Diseases|February 12, 2020
Prioritising pathogens for the management of severe febrile patients to improve clinical care in low- and middle-income countriesJennifer Osborn, Teri Roberts, Ethan Guillen, et al.
Emerging Infectious Diseases|February 21, 2025
Adaptive Design for Phase II/III Platform Trial of Lassa Fever TherapeuticsJosephine Bourner, Michel Vaillant, Alex Paddy Abdel Salam, et al.
Pageof 5